View Author
patient cancer study induction chemotherapy induction chemotherapy radiotherapy surgery stage survival trial treatment response resection nsclc non-small mediastinal arm b disease result phase oncol therapy tumor toxicity induction therapy carboplatin gemcitabine chemoradiotherapy grade eortc group cycle lymph center number radiotherapy arm cisplatin lung cancer department table randomized n 3 disease induction treatment 3–4 institute day 8 thoracic ziekenhui analysis re-mediastinoscopy surgery arm 109/ l randomized trial non-small-cell lung cancer iiia-n progression-free survival thrombocytopenia day 1 response rate mortality month randomization outcome postoperative pneumonectomy downstaging postoperative radiotherapy van schil p schil mediastinal lymph nodes platelet mediastinal clearance stage iiia kaplan –meier analyses cancer institute radiation interval thorac regimen
3 Most Recent Publications
|
A randomized phase II study comparing two schedules of the 21-day regimen of gemcitabine and carboplatin in advanced non-small cell lung cancer
(Article)
Surmont, V. Aerts, J.G.J.V. Klaveren, R.J. van Tournoy, K. Tan, K.Y. Vernhout, R. Schmitz, P.I.M. Legrand, C. Hoogsteden, H.C. Meerbeeck, J.P. van |
2010-06-01
|
|
Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer
(Article)
Meerbeeck, J.P. van Kramer, G.W.P.M. Splinter, T.A.W. Giaccone, G. Schil, P.E.Y. van Legrand, C. Smit, E.F. Schramel, F.M.N.H. Tjan-Heijnen, V.C.G. Biesma, B. Debruyne, C. Zandwijk, N. van |
2007-03-21
|
|
Lessons to learn from EORTC study 08981: A feasibility study of induction chemoradiotherapy followed by surgical resection for stage IIIB non-small cell lung cancer
(Article)
Surmont, V. Klaveren, R.J. van Goor, C. Schramel, F.M.N.H. Manegold, C. Legrand, C. Schil, P.E.Y. van Meerbeeck, J.P. van |
2007-01-01
|